Intrahepatic Cholangiocarcinoma Clinical Trials in Fuzhou, Fujian
2 recruitingFuzhou, Fujian, China
Showing 1–2 of 2 trials
Recruiting
D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital37 enrolled1 locationNCT06643208
Recruiting
Early Phase 1
Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection
Intrahepatic Cholangiocarcinoma
Yongyi Zeng10 enrolled1 locationNCT06406816